IVBH Presents Groundbreaking Data for Early Lung Cancer Detection at the ASCO® 2023 Annual Meeting

IVBH’s novel RNA approach to early detection demonstrates strong sensitivity and specificity for early lung cancer detection, in a large, predominantly early-stage, independent validation cohort NEWPORT BEACH, Calif., June 2, 2023 /PRNewswire/ — IVBH, a leader in liquid biopsy technology, specializing in noninvasive early detection, will unveil groundbreaking data from an independent validation study of the … Read more